166 related articles for article (PubMed ID: 36961655)
21. Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer.
Zheng Y; Wang Z; Wei S; Liu Z; Chen G
Cancer Lett; 2021 Feb; 499():148-163. PubMed ID: 33253790
[TBL] [Abstract][Full Text] [Related]
22. Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation.
Takaishi K; Komohara Y; Tashiro H; Ohtake H; Nakagawa T; Katabuchi H; Takeya M
Cancer Sci; 2010 Oct; 101(10):2128-36. PubMed ID: 20860602
[TBL] [Abstract][Full Text] [Related]
23. NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer.
Rao X; Zhou X; Wang G; Jie X; Xing B; Xu Y; Chen Y; Li J; Zhu K; Wu Z; Wu G; Wu C; Zhou R
Cell Death Dis; 2022 Oct; 13(10):891. PubMed ID: 36270983
[TBL] [Abstract][Full Text] [Related]
24. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
[TBL] [Abstract][Full Text] [Related]
25. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.
Pan T; Zhang F; Li F; Gao X; Li Z; Li X; Ren X
Oncol Rep; 2020 Sep; 44(3):1049-1063. PubMed ID: 32705271
[TBL] [Abstract][Full Text] [Related]
26. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
27. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma.
Yin Z; Ma T; Lin Y; Lu X; Zhang C; Chen S; Jian Z
J Cell Biochem; 2018 Nov; 119(11):9419-9432. PubMed ID: 30015355
[TBL] [Abstract][Full Text] [Related]
28. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
29. Signal transducer and activator of transcription 3 downregulation in J774A.1 cell line as a model of M2 macrophages in tumor microenvironment.
Seyedi Z; Hashemzadeh MR; Colagar AH; Jaafari MR
J Cancer Res Ther; 2018; 14(5):1121-1125. PubMed ID: 30197360
[TBL] [Abstract][Full Text] [Related]
30. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
31. Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer.
Pfeiffer M; Hartmann TN; Leick M; Catusse J; Schmitt-Graeff A; Burger M
Br J Cancer; 2009 Jun; 100(12):1949-56. PubMed ID: 19455144
[TBL] [Abstract][Full Text] [Related]
32. JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis.
Chen S; Wang M; Lu T; Liu Y; Hong W; He X; Cheng Y; Liu J; Wei Y; Wei X
Oncogene; 2023 Sep; 42(37):2737-2750. PubMed ID: 37567973
[TBL] [Abstract][Full Text] [Related]
33. ALDH3A1 overexpression in OSCC inhibits inflammation via phospho-Ser727 at STAT3 in tumor-associated macrophages.
Wang B; He Y; Wang B; Li J; Qin L
Oral Dis; 2023 May; 29(4):1513-1524. PubMed ID: 35188323
[TBL] [Abstract][Full Text] [Related]
34. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract][Full Text] [Related]
35. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3.
Fujiwara Y; Komohara Y; Kudo R; Tsurushima K; Ohnishi K; Ikeda T; Takeya M
Oncol Rep; 2011 Dec; 26(6):1533-7. PubMed ID: 21922144
[TBL] [Abstract][Full Text] [Related]
36. The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6.
Yin Y; Yao S; Hu Y; Feng Y; Li M; Bian Z; Zhang J; Qin Y; Qi X; Zhou L; Fei B; Zou J; Hua D; Huang Z
Clin Cancer Res; 2017 Dec; 23(23):7375-7387. PubMed ID: 28928161
[No Abstract] [Full Text] [Related]
37. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
[TBL] [Abstract][Full Text] [Related]
38. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
[TBL] [Abstract][Full Text] [Related]
39. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
[TBL] [Abstract][Full Text] [Related]
40. Role of Stat3 activation in cell-cell interaction between B-cell lymphoma and macrophages: the in vitro study.
Bai B; Horlad H; Saito Y; Ohnishi K; Fujiwara Y; Takeya M; Komohara Y
J Clin Exp Hematop; 2013; 53(2):127-33. PubMed ID: 23995109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
